- Aug 14, 2013
- 2,455
- Tinnitus Since
- Resolved since 2016
- Cause of Tinnitus
- Unknown (medication, head injury)
Dear worldwide tinnitus community,
In the past few days, and after the failure of the QUIET-1 study, there has been an attempt to increase awareness of the work of the scientists behind the following paper on four different potassium channel openers - one of which is Trobalt/Retigabine:
www.researchgate.net/publication/261220232_Pharmacodynamics_of_potassium_channel_openers_in_cultured_neuronal_networks
The paper, above, presents theoretical (in vitro) evidence of Trobalt being a potent drug to eliminate symptoms of tinnitus and coupled with the informal evidence from some members of this board who have tried the medication, there seems to be sufficient indications that Trobalt should be investigated further in relation to the treatment of tinnitus. The best way to create attention is to do just that: create attention - or awareness. In addition, a more formal study should be undertaken in order to better understand (from a human perspective):
So supporting their work and raising awareness is important indeed.
Regarding advocacy, during the last 3-4 days, I have monitored the "read"-activity related to their publication:
As can be seen, there has been a steep climb in activity. So spreading the message does work.
If there are members of the forum who wish to contribute to advocacy, feel free to write concrete steps for doing so or ask to join Team Awareness. Raising awareness and advocacy is relatively easy, but requires persistence to get results. Examples include:
http://www.dailymail.co.uk/health/a...TINNITUS-reduces-hyperactivity-cells-ear.html
...to let her know about the results obtained here on the forum, and, ask her if she would be willing to do another article. These are the kind of relatively simple steps that can be taken.
Lastly, please be kind to keep this thread on topic. Only relevant input please. Don't let it drift off-course. Thanks.
attheedgeofscience
16/OCT/2015.
In the past few days, and after the failure of the QUIET-1 study, there has been an attempt to increase awareness of the work of the scientists behind the following paper on four different potassium channel openers - one of which is Trobalt/Retigabine:
www.researchgate.net/publication/261220232_Pharmacodynamics_of_potassium_channel_openers_in_cultured_neuronal_networks
The paper, above, presents theoretical (in vitro) evidence of Trobalt being a potent drug to eliminate symptoms of tinnitus and coupled with the informal evidence from some members of this board who have tried the medication, there seems to be sufficient indications that Trobalt should be investigated further in relation to the treatment of tinnitus. The best way to create attention is to do just that: create attention - or awareness. In addition, a more formal study should be undertaken in order to better understand (from a human perspective):
- Treatment protocol and duration
- Efficacy in relation to etiologies
- Efficacy in relation to chronicity of tinnitus
- Maintenance of efficacy (after tapering down)
- Other topics of concern/interest (for instance, side effects)
...A snapshot of the findings is that we can treat tinnitus, with pre- and post-treatment results that are significant. While this is a case study, perhaps a clinical trial of this nature could be done using Trobalt and, of course, including more patients.
There is therefore good reason to support awareness of the work of the researchers: they are aware that there people who have seen benefits from trying it. But funding for research has been cut. As evidence of this, I will release additional information from two of the five co-authors of the paper (but I will not name them):Thank you for your most recent email, as well as your earlier correspondence of last week. We continue to be interested in the efforts you are making towards tinnitus treatment - congratulations on your most recent progress to engage others interested in tinnitus. We would reiterate that our contributions lie within three spheres of research activity: (1) Our basic science research consisting of in vitro recordings of tinnitus-like activity, and the re-purposing of drugs to minimize increased neuronal activity and bursting phenomenon, (2) Our basic science in vivo experimentation using the zebrafish as an experimental model for tinnitus-like activity, and (3) The use of fMRI imaging protocols with humans suffering from tinnitus by employing re-purposed or over-the-counter supplements in an attempt to alleviate tinnitus. Thus, as regards the latter, we have already in place the basic milieu to continue to test the efficacy of Trobalt (Retigabine). Fundamental to our basic and translational research activities is a comprehensive Tinnitus Clinic as part of our UNT Speech and Hearing Center that evaluates patients suffering from tinnitus, and make recommendation for treatment.
Thank you for your recent e-mail. Although the in vitro research was done in my lab, Dr. Moore is the expert on tinnitus. I have already suggested that we should quantify the neurotoxicity of this compound before we address specific mechanisms. However, we do not have the resources to start new projects. Support for research has been cut substantially.
Thank you for your interest in the work. We do not know the mechanism of how retigabine (Trobalt) decreases induced firing of neurons, or whether this activity could suppress symptoms of tinnitus. In light of the known side effects of the drug (blue eyes, skin, tremor, etc) it is not likely to be useful for treating tinnitus, especially long term. Dr. Moore's lab is currently working on potentially more effective alternatives with fewer or no side effects. However, securing funding for this research remains an uphill battle.
So supporting their work and raising awareness is important indeed.
Regarding advocacy, during the last 3-4 days, I have monitored the "read"-activity related to their publication:
As can be seen, there has been a steep climb in activity. So spreading the message does work.
If there are members of the forum who wish to contribute to advocacy, feel free to write concrete steps for doing so or ask to join Team Awareness. Raising awareness and advocacy is relatively easy, but requires persistence to get results. Examples include:
- Contacting journalists
- Contacting health authorities
- Contacting interest groups that may have a direct or indirect interest in tinnitus (ATA, BTA)
- Donating money for e.g. sponsored ads on Facebook
http://www.dailymail.co.uk/health/a...TINNITUS-reduces-hyperactivity-cells-ear.html
...to let her know about the results obtained here on the forum, and, ask her if she would be willing to do another article. These are the kind of relatively simple steps that can be taken.
Lastly, please be kind to keep this thread on topic. Only relevant input please. Don't let it drift off-course. Thanks.
attheedgeofscience
16/OCT/2015.